Adenosine dose should be less when administered through a central line 1 1Pharmacology in Emergency Medicine is coordinated by Richard F. Clark, md of the University of California San Diego Medical Center, San Diego, California
- 1 February 2002
- journal article
- Published by Elsevier BV in The Journal of Emergency Medicine
- Vol. 22 (2), 195-198
- https://doi.org/10.1016/s0736-4679(01)00464-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Supraventricular tachycardia: Implications for the intensivistCritical Care Medicine, 2000
- Antiarrhythmic agents and proarrhythmiaCritical Care Medicine, 2000
- Risk of atrioventricular block during adenosine pharmacologic stress testing in heart transplant recipientsThe American Journal of Cardiology, 1998
- Mechanisms of Adenosine-Mediated Actions on Cellular and Clinical Cardiac ElectrophysiologyMayo Clinic Proceedings, 1995
- Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardiaJournal of the American College of Cardiology, 1993
- Adenosine for Paroxysmal Supraventricular Tachycardia: Dose Ranging and Comparison with VerapamilAnnals of Internal Medicine, 1990
- The cardiac effects of adenosineProgress in Cardiovascular Diseases, 1989
- Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmiasJournal of the American College of Cardiology, 1985
- Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.Circulation, 1983
- Dipyridamole inhibition of adenosine metabolism in human bloodEuropean Journal of Pharmacology, 1983